![glp-1 hearing loss Risk of in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-18-00735/article_deploy/html/images/pharmaceuticals-18-00735-g004.png)
glp-1 hearing loss Risk of in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors glp-1_analogs [TUSOM | Pharmwiki]
Description
Anesthesia was induced using isoflurane, and animals were sacrificed by cervical dislocation under isoflurane anesthesia
![glp-1 hearing loss Risk of in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and SodiumGlucose Cotransporter 2 Inhibitors glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Whether Liraglutide mitigated the harmful effects of high-glucose (HG) therapy on lab-grown vascular smooth muscle cells (VSMCs) or not was examined
![glp-1 hearing loss Risk of in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and SodiumGlucose Cotransporter 2 Inhibitors glp-1_analogs [TUSOM | Pharmwiki]](https://www.uwosh.edu/today/wp-content/uploads/sites/93/GLP1-1080x675.jpg)
That compared to a 2.2 percent decrease for participants taking an oral placebo pill
![glp-1 hearing loss Risk of in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and SodiumGlucose Cotransporter 2 Inhibitors glp-1_analogs [TUSOM | Pharmwiki]](https://nypost.com/wp-content/uploads/sites/2/2026/05/GLP-1-drugs-V2.jpg?quality=75&strip=all&w=1200)
Patent expiration for semaglutide in some of the worlds biggest markets will also be an opportunity for companies that dont make finished drugs but instead focus on active pharmaceutical ingredients
